Sign Up Today and Learn More About Cagent Vascular Stock
Invest in or calculate the value of your shares in Cagent Vascular or other pre-IPO companies through EquityZen's platform.

Cagent Vascular Stock (CAVA)
Cagent Vascular develops a serration technology for improving the treatment of cardiovascular disease.
About Cagent Vascular Stock
Founded
2014
Headquarters
Wayne, PA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Cagent Vascular Press Mentions
Stay in the know about the latest news on Cagent Vascular
Cagent Vascular Announces Launch of New Product Serranator SL-PRO for CLTI and Pedal Disease
businesswire • Feb 03, 2025
Cagent Vascular Initiates the Serranator® POINT FORCE Observational Registry
businesswire • Jan 28, 2025
Cagent Vascular Initiates the Serranator® POINT FORCE Observational Registry
biospace • Jan 28, 2025
Cagent Vascular names former Carl Zeiss Meditech exec as CEO
massdevice • May 20, 2024
Cagent Vascular appoints Chairman Brian Walsh to expanded role as Chief Executive Officer
businesswire • May 07, 2024
Cagent Vascular Management
Leadership team at Cagent Vascular
Co-Founder, President & CEO
Carol A. Burns
Founder, CTO, and VP of Research and Development
Robert M. Giasolli

Join now and verify your accreditation status to gain access to:
- Cagent Vascular Current Valuation
- Cagent Vascular Stock Price
- Cagent Vascular Management
- Available deals in Cagent Vascular and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Cagent Vascular Cap Table and Funding History by Share Class and Liquidity Preferences
- Cagent Vascular Revenue and Financials
- Cagent Vascular Highlights
- Cagent Vascular Business Model
- Cagent Vascular Risk Factors
- Cagent Vascular Research Report from SACRA Research
Trading Cagent Vascular Stock
How to invest in Cagent Vascular stock?
Accredited investors can buy pre-IPO stock in companies like Cagent Vascular through EquityZen funds. These investments are made available by existing Cagent Vascular shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Cagent Vascular stock?
Shareholders can sell their Cagent Vascular stock through EquityZen's private company marketplace. EquityZen's network includes over 340K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 44K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."